98%
921
2 minutes
20
Understanding vegetation responses to climate change on the Tibetan Plateau (TP) helps in elucidating the land-atmosphere energy exchange, which affects air mass movement over and around the TP. Although the TP is one of the world's most sensitive regions in terms of climatic warming, little is known about how the vegetation responds. Here, we focus on how spring phenology and summertime greenness respond to the asymmetric warming, that is, stronger warming during nighttime than during daytime. Using both in situ and satellite observations, we found that vegetation green-up date showed a stronger negative partial correlation with daily minimum temperature (Tmin ) than with maximum temperature (Tmax ) before the growing season ('preseason' henceforth). Summer vegetation greenness was strongly positively correlated with summer Tmin , but negatively with Tmax . A 1-K increase in preseason Tmin advanced green-up date by 4 days (P < 0.05) and in summer enhanced greenness by 3.6% relative to the mean greenness during 2000-2004 (P < 0.01). In contrast, increases in preseason Tmax did not advance green-up date (P > 0.10) and higher summer Tmax even reduced greenness by 2.6% K(-1) (P < 0.05). The stimulating effects of increasing Tmin were likely caused by reduced low temperature constraints, and the apparent negative effects of higher Tmax on greenness were probably due to the accompanying decline in water availability. The dominant enhancing effect of nighttime warming indicates that climatic warming will probably have stronger impact on TP ecosystems than on apparently similar Arctic ecosystems where vegetation is controlled mainly by Tmax . Our results are crucial for future improvements of dynamic vegetation models embedded in the Earth System Models which are being used to describe the behavior of the Asian monsoon. The results are significant because the state of the vegetation on the TP plays an important role in steering the monsoon.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/gcb.13301 | DOI Listing |
JAMA Intern Med
September 2025
Bayer CC AG, Basel, Switzerland.
Importance: There is an unmet need for long-term, safe, effective, and hormone-free treatments for menopausal symptoms, including vasomotor symptoms (VMS) and sleep disturbances.
Objective: To evaluate the 52-week efficacy and safety of elinzanetant, a dual neurokinin-targeted therapy, for treating moderate to severe VMS associated with menopause.
Design, Setting, And Participants: OASIS-3 was a double-blind, placebo-controlled, randomized phase 3 clinical trial that was conducted at 83 sites in North America and Europe from August 27, 2021, to February 12, 2024, and included postmenopausal women aged 40 to 65 years who were seeking treatment for moderate to severe VMS (no requirement for a minimum number of VMS events per week).
Adv Ther
September 2025
Teva Branded Pharmaceutical Products R&D LLC, West Chester, PA, USA.
Introduction: Pharmacokinetic differences between long-acting injectable antipsychotic (LAI) formulations, combined with a lack of clinical switch studies, contribute to clinician uncertainty when transitioning between LAIs. This analysis employed a population pharmacokinetic (popPK) modeling approach to characterize dosing conversions and switching strategies from intramuscular paliperidone palmitate once monthly (PP1m) to TV-46000, a long-acting subcutaneous formulation of risperidone, once monthly (q1m), with a secondary analysis of PP1m to TV-46000 every 2 months (q2m).
Methods: For PP1m and TV-46000, concentration-time profiles for paliperidone and TV-46000 total active moiety (TAM; risperidone + paliperidone) were simulated on the basis of published popPK models with virtual populations of 5000 patients.
Objective: This study used data from early stages of non-medical cannabis legalization in Washington State to 1) Compare cannabis dispensary density measures by urbanicity, 2) Test if dispensary density was associated with cannabis use overall and by urbanicity.
Method: Data are from the Privatization of Spirits in Washington Surveys ( = 2,162 adults) and licensing records. We graphed six cannabis dispensary density measures by urbanicity.
Neurocrit Care
September 2025
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.
Background: Levetiracetam, a first-line antiseizure medication, is primarily eliminated through the kidneys, with approximately 66% renal elimination. Consequently, its pharmacokinetics are significantly influenced by kidney function. Augmented renal clearance (ARC), a condition characterized by renal hyperfiltration, is frequently observed in critical care settings and can profoundly impact the disposition of renally eliminated drugs such as levetiracetam.
View Article and Find Full Text PDFBone Jt Open
September 2025
Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Julius Wolff Institute, Berlin, Germany.
Aims: This retrospective observational study aimed to determine the in vivo joint loads in the knee after total knee arthroplasty during early postoperative rehabilitation involving different physiotherapy exercises and to analyze how these loads change over the first three weeks postoperatively.
Methods: Nine patients (six males, three females) with a primary instrumented total knee replacement participated in the study. A total of 19 selected physical therapy exercises of varying load levels were performed on the ninth (SD 3) and 21st (SD 6) postoperative day.